LAG3 and neoplasm: In ELISpot assay using MKN45, up-regulation of IFN-γ production from CTL clones was observed when CTL clones were reactivated with anti-PD-1 or anti-Lag-3 mAb, or tumor cells treated with anti-PD-L1 mAb (Fig. 3a).